Real-time enrollment status for this macular degeneration clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 5:01 AM UTC
| NCT Number | NCT03683251 |
| Recruiting Status | Recruiting |
| Condition | Macular Degeneration |
| Phase | Clinical Trial |
| Target Enrollment | 1,000 participants |
| Active Locations | 81 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | March 30, 2026 (2 weeks ago) |
As of April 17, 2026: Clinical trial NCT03683251 is currently recruiting participants. This clinical trial study for macular degeneration is actively seeking new participants at 81 locations across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03683251 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 81 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03683251 was last updated 2 weeks ago (March 30, 2026). HelloStudys verifies this status automatically.